| Lastest Insider Transactions Of EyePoint Pharmaceuticals, Inc. ( EYPT ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| EYPT | EyePoint Pharmaceuticals, Inc. | Cormorant Asset Management, LP | 10% Owner | 2024-04-18 | Buy | 581,765 | 18.03 | 10,489,446 | 2024-04-22 16:00:41 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | 2024-03-30 | Option Exercise | 50,404 | 0.00 | 0 | 2024-04-02 17:27:52 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Lurker Nancy | Executive Vice Chair | 2024-02-09 | Option Exercise | 37,534 | 0.00 | 0 | 2024-02-13 17:40:49 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | 2024-02-09 | Option Exercise | 10,800 | 0.00 | 0 | 2024-02-13 17:39:24 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | 2024-02-09 | Option Exercise | 9,967 | 0.00 | 0 | 2024-02-13 17:38:56 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Elston George | Chief Financial Officer | 2024-02-09 | Option Exercise | 10,800 | 0.00 | 0 | 2024-02-13 17:38:49 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Duker Jay S. | President and CEO | 2024-02-09 | Option Exercise | 11,967 | 0.00 | 0 | 2024-02-13 17:37:59 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | 2024-02-02 | Sell | 209 | 28.49 | 5,954 | 2024-02-05 17:15:56 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | 2024-02-02 | Option Exercise | 209 | 11.47 | 2,397 | 2024-02-05 17:15:56 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | 2024-01-26 | Sell | 49,325 | 25.66 | 1,265,539 | 2024-01-30 16:53:11 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | 2024-01-26 | Option Exercise | 49,325 | 13.06 | 644,047 | 2024-01-30 16:53:11 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | 2024-01-26 | Sell | 26,017 | 25.38 | 660,371 | 2024-01-29 17:54:06 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | 2024-01-26 | Option Exercise | 26,017 | 6.82 | 177,398 | 2024-01-29 17:54:06 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | 2024-01-25 | Sell | 600 | 25.00 | 15,000 | 2024-01-29 17:51:57 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | 2024-01-25 | Option Exercise | 600 | 13.02 | 7,809 | 2024-01-29 17:51:57 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | 2024-01-24 | Sell | 11,900 | 25.01 | 297,621 | 2024-01-26 17:03:44 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | 2024-01-24 | Option Exercise | 11,900 | 8.04 | 95,670 | 2024-01-26 17:03:44 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | 2024-01-23 | Sell | 16,386 | 25.01 | 409,790 | 2024-01-25 18:26:21 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | 2024-01-23 | Option Exercise | 16,386 | 13.02 | 213,379 | 2024-01-25 18:26:21 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Lurker Nancy | Executive Vice Chair | 2024-01-23 | Sell | 35,000 | 24.98 | 874,200 | 2024-01-25 18:24:43 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | 2024-01-22 | Sell | 35,066 | 22.68 | 795,191 | 2024-01-24 16:50:28 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | 2024-01-22 | Option Exercise | 35,066 | 10.27 | 360,149 | 2024-01-24 16:50:28 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Cormorant Asset Management, LP | 10% Owner | 2024-01-09 | Buy | 855,000 | 19.94 | 17,051,100 | 2024-01-11 16:00:52 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | 2024-01-08 | Sell | 22,913 | 21.13 | 484,124 | 2024-01-10 16:53:57 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | 2024-01-08 | Option Exercise | 22,913 | 3.26 | 74,696 | 2024-01-10 16:53:57 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | 2024-01-05 | Option Exercise | 15,285 | 0.00 | 0 | 2024-01-09 21:28:57 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Lurker Nancy | Executive Vice Chair | 2024-01-05 | Option Exercise | 75,133 | 0.00 | 0 | 2024-01-09 21:17:24 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Pine Michael Craig | Chief Corp Dev.&Strat. Officer | 2024-01-05 | Option Exercise | 15,285 | 0.00 | 0 | 2024-01-09 21:11:46 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | 2024-01-05 | Option Exercise | 15,285 | 0.00 | 0 | 2024-01-09 21:09:02 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Duker Jay S. | President and CEO | 2024-01-05 | Option Exercise | 20,793 | 0.00 | 0 | 2024-01-09 21:07:56 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Elston George | Chief Financial Officer | 2024-01-05 | Option Exercise | 15,285 | 0.00 | 0 | 2024-01-09 21:04:27 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | 2023-12-13 | Sell | 1,458 | 20.00 | 29,160 | 2023-12-15 17:14:10 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | 2023-12-13 | Option Exercise | 1,458 | 10.13 | 14,770 | 2023-12-15 17:14:10 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Cormorant Asset Management, LP | 10% Owner | 2023-12-08 | Buy | 588,235 | 17.00 | 9,999,995 | 2023-12-12 16:52:16 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Pine Michael Craig | Chief Corp Dev.&Strat. Officer | 2023-12-04 | Sell | 46,000 | 21.97 | 1,010,790 | 2023-12-11 16:15:33 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Pine Michael Craig | Chief Corp Dev.&Strat. Officer | 2023-12-04 | Option Exercise | 45,000 | 12.62 | 567,900 | 2023-12-11 16:15:33 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Pine Michael Craig | Chief Corp Dev.&Strat. Officer | 2023-12-04 | Sell | 45,000 | 22.00 | 990,000 | 2023-12-06 17:20:23 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Pine Michael Craig | Chief Corp Dev.&Strat. Officer | 2023-12-04 | Option Exercise | 45,000 | 12.62 | 567,900 | 2023-12-06 17:20:23 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | 2023-12-04 | Sell | 30,625 | 22.00 | 673,750 | 2023-12-06 17:19:35 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | 2023-12-04 | Option Exercise | 30,625 | 10.13 | 310,231 | 2023-12-06 17:19:35 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Lurker Nancy | Executive Vice Chair | 2023-12-04 | Sell | 20,000 | 20.76 | 415,200 | 2023-12-06 17:18:48 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Cormorant Asset Management, LP | 10% Owner | 2023-12-04 | Buy | 1,919,057 | 21.82 | 41,874,152 | 2023-12-06 16:39:15 |
| EYPT | EyePoint Pharmaceuticals, Inc. | EW Healthcare Partners, L.P. | 10% Owner | 2023-09-01 | Sell | 20,000 | 9.90 | 197,982 | 2023-09-06 19:10:14 |
| EYPT | EyePoint Pharmaceuticals, Inc. | EW Healthcare Partners, L.P. | 10% Owner | 2023-09-01 | Sell | 20,000 | 9.90 | 197,982 | 2023-09-06 17:14:16 |
| EYPT | EyePoint Pharmaceuticals, Inc. | EW Healthcare Partners, L.P. | 10% Owner | 2023-08-30 | Sell | 139,471 | 10.54 | 1,470,208 | 2023-09-01 16:51:44 |
| EYPT | EyePoint Pharmaceuticals, Inc. | EW Healthcare Partners, L.P. | 10% Owner | 2023-08-28 | Sell | 148,712 | 11.14 | 1,656,878 | 2023-08-30 17:46:38 |
| EYPT | EyePoint Pharmaceuticals, Inc. | EW Healthcare Partners, L.P. | 10% Owner | 2023-08-24 | Sell | 223,936 | 11.11 | 2,487,482 | 2023-08-30 17:32:53 |
| EYPT | EyePoint Pharmaceuticals, Inc. | EW Healthcare Partners, L.P. | 10% Owner | 2023-08-24 | Sell | 223,936 | 13.25 | 2,967,572 | 2023-08-28 18:32:40 |
| EYPT | EyePoint Pharmaceuticals, Inc. | EW Healthcare Partners, L.P. | 10% Owner | 2023-08-22 | Sell | 167,881 | 13.49 | 2,264,749 | 2023-08-24 17:30:14 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Zaderej Karen L. | Directior | 2023-07-11 | Option Exercise | 2,000 | 0.00 | 0 | 2023-07-12 18:51:43 |
| EYPT | EyePoint Pharmaceuticals, Inc. | ADAMIS ANTHONY P | Directior | 2023-06-23 | Option Exercise | 2,000 | 0.00 | 0 | 2023-06-26 17:10:44 |
| EYPT | EyePoint Pharmaceuticals, Inc. | GUYER DAVID R | Directior | 2023-02-09 | Option Exercise | 3,000 | 0.00 | 0 | 2023-02-13 17:08:38 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Paggiarino Dario A. | Chief Medical Officer | 2023-02-09 | Option Exercise | 10,800 | 0.00 | 0 | 2023-02-13 17:07:53 |
| EYPT | EyePoint Pharmaceuticals, Inc. | DICICCO WENDY F | Directior | 2023-02-09 | Option Exercise | 3,000 | 0.00 | 0 | 2023-02-13 17:06:03 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Landis John B. | Directior | 2023-02-09 | Option Exercise | 3,000 | 0.00 | 0 | 2023-02-13 17:05:33 |
| EYPT | EyePoint Pharmaceuticals, Inc. | ANDO GORAN | Directior | 2023-02-09 | Option Exercise | 3,250 | 0.00 | 0 | 2023-02-13 17:04:42 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Duker Jay S. | President and COO | 2023-02-09 | Option Exercise | 11,967 | 0.00 | 0 | 2023-02-13 17:03:38 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Jones David Scott | SVP & Chief Commercial Officer | 2023-02-09 | Option Exercise | 9,967 | 0.00 | 0 | 2023-02-13 17:02:39 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Elston George | Chief Financial Officer | 2023-02-09 | Option Exercise | 10,800 | 0.00 | 0 | 2023-02-13 16:58:25 |
| EYPT | EyePoint Pharmaceuticals, Inc. | Lurker Nancy | CEO | 2023-02-09 | Option Exercise | 37,533 | 0.00 | 0 | 2023-02-13 16:56:53 |
